SKYCovione: SK Bioscience’s Protein-Based COVID-19 Vaccine
SK Bioscience developed SKYCovione, a recombinant protein-based COVID-19 vaccine approved in South Korea in 2022. Unlike mRNA technology, it uses a nanoparticle design to mimic the virus’s structure, triggering an ... Read More